SCHEMBL5595232

SCHEMBL5595232

c1ccc2c(c1)Cc1cc(CNCCCN3CCNCC3)ccc1-2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.47
CYP2D6 P10635 2/20 0.47
TSHR P16473 2/20 0.45
NPC1 O15118 1/20 0.45
TP53 P04637 1/20 0.45
MAPK1 P28482 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
DRD2 P14416 4/20 0.45
DRD3 P35462 4/20 0.45
DRD4 P21917 2/20 0.44
SIGMAR1 Q99720 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
ALOX15 P16050 1/20 0.42
HTT P42858 1/20 0.41
FAAH O00519 1/20 0.40
PARP1 P09874 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2446291 0.92 DRD2 (0.51) CYP3A4CYP2D6TSHRNPC1TP53
SCHEMBL5604920 0.79 SLC6A4 (0.64) CYP3A4CYP2D6TSHRSIGMAR1L3MBTL1
SCHEMBL5595495 0.76 CYP3A4 (0.55) CYP3A4CYP2D6TSHRSMN1; SMN2SIGMAR1
SCHEMBL5595644 0.73 CYP3A4 (0.57) CYP3A4CYP2D6TSHRSIGMAR1L3MBTL1
SCHEMBL9080133 0.72 ALDH1A1 (0.50) CYP3A4TSHRNPC1TP53MAPK1
SCHEMBL5595494 0.72 KDM4E (0.58) TP53KDM4E
SCHEMBL13973037 0.71 TSHR (0.52) CYP3A4CYP2D6TSHRNPC1TP53
SCHEMBL26099817 0.71 CA12 (0.55) CYP2D6TSHRDRD2DRD3KDM4E
SCHEMBL5595516 0.70 CHRM2 (0.57) CYP3A4CYP2D6DRD2DRD3SIGMAR1
SCHEMBL9048454 0.70 DPP7 (0.73) CYP3A4CYP2D6TSHRSIGMAR1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1809288-A1 USE OF 1,4-BIS (3-AMINOALKYL) PIPERAZINE DERIVATIVES IN THE TREATMENT OF NEURODEGENERATIVE DISEASES INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2007-07-25 EP disclosed
WO-2006051489-A1 USE OF 1,4-BIS (3-AMINOALKYL) PIPERAZINE DERIVATIVES IN THE TREATMENT OF NEURODEGENERATIVE DISEASES INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2006-05-18 WO disclosed